神经创伤或神经外科术后早期接种肺炎球菌多糖疫苗
研究纳入33例颅底骨折和23例经蝶垂体手术患者在神经创伤或神经外科术后10天内接种肺炎球菌多糖疫苗(PPSV),另以29例术后≥3周接种的神经外科患者为对照,采用酶免疫法检测7种血清型特异性IgG抗体。结果显示接种安全,所有组对所有血清型抗体反应均高度显著(p<0.001),组间及组别与时间交互作用均无差异;早期与晚期接种后,9V、14、18C、19F和23F血清型保护水平>80%,6B和4血清型分别为70%和50%。结论认为PPSV可在神经创伤或神经外科术后早期接种。
要点
- 神经创伤或神经外科术后10天内接种PPSV安全,所有组对所有血清型抗体反应均高度显著(p<0.001)。
- 早期接种组与≥3周接种组各血清型抗体反应均无差异,组别与时间交互作用亦无差异。
- 接种后9V、14、18C、19F和23F血清型保护水平>80%,6B和4血清型分别为70%和50%。
核心结论
- 神经创伤或神经外科术后10天内接种PPSV的患者应答与≥3周后接种者相似,表明PPSV可在神经创伤或神经外科术后早期接种。
研究设计与样本
- 研究纳入33例颅底骨折和23例经蝶垂体手术患者,在神经创伤或神经外科术后10天内接种PPSV。
- 以29例在神经创伤或神经外科术后≥3周接种PPSV的神经外科患者为对照。
- 采用酶免疫法测定血清型4、6B、9V、14、18C、19F和23F特异性抗多糖结合IgG抗体水平。
- 临床试验注册号NCT02806284。
主要发现
- 接种安全,所有组对所有血清型均发现高度显著的抗体反应(每个血清型p<0.001)。
- 各血清型组间比较及组别与时间交互作用均无差异。
- 早期和晚期接种后,9V、14、18C、19F和23F血清型保护水平>80%,6B和4血清型分别为70%和50%。
临床怎么用
- 作者认为PPSV可在神经创伤或神经外科术后早期接种。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Pneumococcal vaccination is recommended to lower the risk of posttraumatic meningitis, and early vaccination may be of importance. After both trauma and central nervous system injury, immune-suppression may occur, which could affect T-cell function and the response to T-cell dependent vaccines. We therefore aimed to investigate the response to early vaccination with a T-cell independent pneumococcal polysaccharide vaccine (PPSV). METHODS: Thirty-three patients with basilar skull fracture and 23 patients undergoing transsphenoidal pituitary gland surgery were vaccinated with PPSV within 10days after neurotrauma or neurosurgery. Twenty-nine neurosurgical patients vaccinated ⩾3weeks after neurotrauma or neurosurgery served as controls. Serotype-specific anti-polysaccharide binding IgG antibody levels to serotypes 4, 6B, 9V, 14, 18C, 19F and 23F were determined by enzyme immunoassay. RESULTS: The vaccination was safe and a highly significant antibody response was found against all serotypes in all groups (p<0.001 for each of the serotypes). There were no differences between groups or in the group by time interaction in any of the serotypes. After early and late vaccination, protective levels were found in >80% for serotypes 9V, 14, 18C, 19F and 23F and in 70% and 50% for serotypes 6B and 4, respectively. CONCLUSION: Patients vaccinated with PPSV within 10days after neurotrauma or neurosurgery respond similarly to those vaccinated after ⩾3weeks, indicating that PPSV can be administered early after neurotrauma or neurosurgery. CLINICAL TRIALS REGISTRATION: NCT02806284.
引用
- Hedberg AL, Pauksens K, Enblad P, et al. Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery. Vaccine. 2017. PMID: 28069358. doi:10.1016/j.vaccine.2016.12.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。